Download CURT J. CARLSON, MD, Pharm.D.

CURT J. CARLSON, M.D., Pharm.D.
Contact Information:
[email protected]
EDUCATION
2001 – 2005
School of Pharmacy
Palm Beach Atlantic University
West Palm Beach, FL
Doctor of Pharmacy Magna Cum Laude
1995 – 1997
Family Practice Residency
Fairfax Family Practice Program
Fairfax, VA
1990 – 1995
School of Medicine
George Washington University
Washington, DC
Doctor of Medicine
1987 – 1988
Department of Biomedical Sciences
University of Connecticut Health Center
Farmington, CT
Molecular Biology Program
1983 – 1987
Rensselaer Polytechnic Institute
Troy, NY
Bachelor of Science, Chemistry
Bachelor of Science, Biology
PROFESSIONAL EXPERIENCE
Jun 2006 – Present
Assistant Professor of Pharmaceutical Science
Gregory School of Pharmacy
Palm Beach Atlantic University
West Palm Beach, FL
 Created Integrated Anatomy, Physiology, and Pathophysiology course
series and Clinical Laboratory and Physical Assessment course
– deliver profession-specific content via lectures and cloud-based
active learning modalities
– compose and administer computer-based assessments to monitor
students’ performance and progressive mastery of course content
– conduct extensive individual tutoring for students
– students earned mean scores > 68th percentile on relevant sections
of the national standardized PCOA exam in 2012 – 2014
 Additional educational content areas include immunology,
pharmacology, and critical thinking
 Received GSOP Teacher of the Year award in 2009, 2011, and 2014
Aug 2014 – Present
Continuing Professional Education Advisory Board Member
MedEDirect
http://www.mededirect.org/index.cfm
 Provide strategic planning and content advisory services
 Review educational materials and provide guidance on tailoring
content to specific professional groups
 Deliver advisory feedback regarding evolving CPE accreditation
standards and educational delivery methods
May 2005 – Apr 2006
Medical Outcomes Consultant
Good Samaritan Medical Center
West Palm Beach, FL
 Conducted efficacy evaluations and cost-effectiveness and costminimization analyses of medications newly-approved by the FDA or
in Phase III clinical trials
 Compared new agents to drug products currently on formulary for
similar indications and made recommendations to the Pharmacy and
Therapeutics (P&T) Committee
 Developed inpatient disease state management protocols with respect
to drug therapy in collaboration with hospital medical staff for
approval by the P&T Committee
– instituted standardized therapeutic protocols for treatment of
systolic heart failure, myocardial infarction, and sickle cell crisis
Oct 1997 – Apr 2000
Attending Physician
Department of Family Practice
OMNI Healthcare
Melbourne, FL
 Provided comprehensive outpatient medical care for patients of all
ages
 Developed, instituted, and provided oversight for the Urgent Care
medical services of OMNI Healthcare
– focused on cost efficiencies while ensuring prompt and excellent
patient care
– OMNI Urgent Care Center achieved profitability within seven
months of operation
 Managed a five-person office staff
Jan 1997 – Oct 1997
Attending Family Practice Physician
Primary Care Specialists of Northern Virginia
Stirling, VA
 Provided longitudinal outpatient medical care for patients of all ages
– diagnosis and management of acute and chronic disease states
– screening health-maintenance physical examinations
– routine gynecologic care
– neonatal care
– treatment of non-operative orthopedic injuries
– minor office dermatologic surgery
2
Jun 1995 – Jan 1997
Family Practice Resident
Fairfax Hospital and Fairfax Family Practice Center
Fairfax, VA
 Provided care to inpatients in various hospital departments and
intensive care units
 Provided outpatient medical care to adult and pediatric patients
– included obstetrics and neonatal care
Service Activities
July 2006 – Present
Curriculum and Academic Policies Committee
Gregory School of Pharmacy
Palm Beach Atlantic University
Vice-Chairman (2008–09)
June 2003 – Nov 2014
Patient Safety Committee
Wellington Regional Medical Center
Wellington, FL
Jan 2007 – Aug 2014
Outcomes Improvement Committee
Gregory School of Pharmacy
Palm Beach Atlantic University
Dec 2011 – Aug 2012
Faculty Advocacy Committee
Gregory School of Pharmacy
Palm Beach Atlantic University
May 2011 – Dec 2011
Pharmacy Faculty Forum
Gregory School of Pharmacy
Palm Beach Atlantic University
Moderator (2011)
June 2010 – Dec 2010
Dean Search Committee
Gregory School of Pharmacy
Palm Beach Atlantic University
May 2005 – Jan 2006
Infection Control Committee
Good Samaritan Medical Center
Member, Antibiotic Use Sub-committee
Feb 2002 – May 2004
Curriculum Committee
School of Pharmacy
Palm Beach Atlantic University
Student Representative (2002–04)
Apr 2002 – Mar 2003
Professional Affairs Committee
Florida Pharmacy Association
3
Pertinent Pharmacy Internships
Mar 2005
Advanced Internal Medicine
JFK Medical Center
Atlantis, FL
 Assessed incidence of reported QTc interval prolongation and
torsades de pointes in patients treated with levofloxacin in a hospital
setting
 Identified potentially correlated factors utilizing FDA Adverse Event
Reporting System and inpatient hospital records
Nov 2004
Oncology
Good Samaritan Medical Center
West Palm Beach, FL
 Reviewed and analyzed primary literature of various new drug entities
awaiting FDA approval
 Presented recommendations on efficacy and pharmacoeconomic
factors to the P&T Committee for formulary consideration
Oct 2004
Hospital Pharmacy Administration
Veterans Affairs Medical Center
West Palm Beach, FL
 Organized and supervised meetings of hospital administrators to
execute ISMP Medication Safety Self-Assessment 2004
 Drafted and submitted Non-Formulary Drug Utilization Criteria to the
P&T Committee for various medications requested by staff physicians
 Analyzed data from a newly-instituted anonymous medication error
reporting system
– produced graphic representation of results for a poster presented
at the 2004 VISN 8 Ambulatory Care Forum
Jul 2004
Pharmaceutical Industry
Pfizer Inc.
Coral Springs, FL
 Initiated and performed data collection for a study comparing the
adverse metabolic effects and pharmacoeconomic outcomes of
ziprasidone and olanzapine in a state psychiatric hospital
 Performed analysis of data from an employee health survey on behalf
of a managed care organization
– provided recommendations for development of health
maintenance programs
 Assessed adherence of physicians to JCAHO-recommended treatment
protocols in a hospital setting for patients admitted in heart failure and
analyzed the rate of subsequent re-admissions
May 2004
Internal Medicine
JFK Medical Center
Atlantis, FL
 Designed the protocol and conducted initial data collection for a study
assessing reversal of warfarin toxicity using vitamin K administered
via various routes of administration
4
– compared intravenous, subcutaneous, and oral routes
– assessed efficacy, adverse events, and outcomes
PROFESSIONAL ACTIVITIES
Clinical Presentations
7 Nov 2005
“Diagnostic and Therapeutic Protocols for Patients with Congestive Heart
Failure”
Pharmacy and Therapeutics Committee
Good Samaritan Medical Center
18 Jul 2005
“Pain Management Protocol for Patients with Sickle Cell Anemia”
Pharmacy and Therapeutics Committee
Good Samaritan Medical Center
26 Jan 2005
“Update on Drug Therapy for Patients with HIV Infection”
Medical Staff Conference
Glades General Hospital
Belle Glade, FL
16 Nov 2004
“Anticoagulation with Ximelagatran vs Warfarin: An Informational
Briefing”
Pharmacy and Therapeutics Committee
Good Samaritan Medical Center
30 Jul 2004
“Ezetimibe/Simvastatin Combination vs Atorvastatin for
Hypercholesterolemia”
Telephone conference for Pfizer pharmaceutical representatives in the
South Florida region
23 Jun 2004
“Ezetimibe/Simvastatin Combination vs Atorvastatin for
Hypercholesterolemia”
Pharmacy Staff Presentation
Veterans Affairs Medical Center
20 May 2004
“ACLS Treatment Protocol for the Patient with Ventricular Fibrillation or
Pulseless Ventricular Tachycardia”
ACLS Training Seminar
JFK Medical Center
Oct 1996
“Diagnosis and Management of Infectious Arthropathies”
Chart Review Presentation: Second Year Residents
Fairfax Family Practice Program
Mar 1996
“Diagnosis and Treatment of Tuberculosis and the Positive PPD”
Topic Presentation: First Year Residents
Fairfax Family Practice Program
Research
Jul 2009
Scott DM, Bennett LL, Ferrill MJ, Brown DL. Pharmacy curriculum
outcomes assessment for individual student assessment and curricular
evaluation. Am J Pharm Ed. 74(10):183, 2010 Dec 15.
5
 Provided correlation coefficient and linear regression statistical
analyses for assessment of the reliability of results from the national
PCOA Exam
Gregory School of Pharmacy
Palm Beach Atlantic University
Jul 2005 – Nov 2005
“Diagnostic and Therapeutic Protocols for Patients with Congestive Heart
Failure”
Good Samaritan Medical Center
May 2005 – Jul 2005
“Pain Management Protocol for Patients with Sickle Cell Anemia”
Good Samaritan Medical Center
Apr 2005
“Minimizing The Risk of QTc Prolongation and Torsades De Pointes
During Levofloxacin Therapy: An Analysis of Data From the FDA
Adverse Event Reporting System”
Department of Pharmacy
JFK Medical Center
Aug 2004
Comparison of the metabolic adverse effects of ziprasidone and olanzapine
and associated outcomes in patients with psychosis
Pfizer, Inc.
Aug 2004
Evaluation of provider adherence to JCAHO inpatient treatment guidelines
and associated rates of re-admission for patients in heart failure
Pfizer, Inc.
May 2004
“Efficacy and Safety of Oral vs Parenteral Phytonadione in the Treatment
of Mild to Moderate Warfarin Toxicity”
Department of Pharmacy
JFK Medical Center
Summer 1991
Evaluation of a rapid qualitative assay for CK-MB in patients presenting to
the Emergency Department with chest pain
Summer Research Program
Department of Emergency Medicine
George Washington University
Spring 1988
“Measurement of Fluid Membrane Dynamics Using Laser Photobleaching
of Fluorescein-Tagged Cell Surface Proteins”
First Year Laboratory Rotation
University of Connecticut Health Center
Farmington, CT
Dennis Koppel, Ph.D.
Professional Affiliations
2001 – Present
American Pharmacists Association
2004 – 2008
American Society of Health-System Pharmacists
2001 – 2008
Florida Pharmacy Association
6
1998 – Present
Florida Medical Society
1991 – Present
American Medical Association
1985 – 1990
American Chemical Society
Organizational Activities
2002 – 2004
Curriculum Committee
School of Pharmacy
Palm Beach Atlantic University
Student Representative (2002-04)
1991 – Present
Lambda Alpha Epsilon Medical Fraternity
George Washington University
1984 – Present
Zeta Psi Fraternity
Pi Chapter, Rensselaer Polytechnic Institute
Representative, Interfraternity Council (1985-86)
WORK EXPERIENCE
Jul 1988 – Jun 1990
Desktop Publisher/Graphic Designer
Investment Marketing Department, CIGNA Insurance
Bloomfield, Connecticut
 Developed marketing presentations, brochures, and other documents
for the CIGNA investment sales force
– utilized publishing/graphics software on a Macintosh platform
 Participated in yearly preparation and publication of the Annual
Report for the CIGNA Investment Group
COMMUNITY SERVICE
June 2011
Science Days summer camp
Palm Beach Atlantic University
West Palm Beach, FL
2001 – 2003
Samaritan Gardens Health Clinic
West Palm Beach, FL
1991 – 1992
KidSupport
Children’s National Medical Center
Washington, DC
1985 – 1986
RIF–Reading Is Fundamental
Troy, NY
Founding Member, Troy Chapter (1985)
AWARDS AND HONORS
2009, 2011, 2014
May 2005
Teacher of the Year Award, PBAU School of Pharmacy
Mylan Excellence in Pharmacy Award, PBAU
7
2005
2001 – 2005
1991
1986 – 1987
1983 – 1984
Rho Chi Pharmacy Honors Society, PBAU
Dean’s List, PBAU
Emergency Medicine Departmental Scholarship, GWU
Dean’s List, RPI
Institute Scholarship, RPI
References Available Upon Request
8